Pulmonology
Latest News
LAMA-LABA surpasses corticosteroid combination as COPD therapy
Large matched cohort study suggests stronger safety and effectiveness outcomes with LAMA-LABA inhalers vs. ICS-LABA inhalers.
From the Journals
Spirometry predicts mortality in type 2 diabetes
PRISm occurs in approximately 10% of the general population and has been identified as a predictor of adverse health outcomes.
From the Journals
Comorbid respiratory disease key predictor of NTM-PD
Overall, comorbid respiratory disease was significantly associated with an increased risk of NTM-PD.
News from the FDA/CDC
CDC signs off on RSV vaccine for older adults
The vote recommending shared decision making about the vaccine, instead of a routine vaccination recommended for all, “is a weaker recommendation...
Latest News
Few of those eligible get lung cancer screening, despite USPSTF recommendations
Fewer than 13% who are eligible get CT screening. Results highlight the need for education, Medicare coverage, and recognition of stigma’s role,...
Sponsored Supplement
Diagnosis and treatment of patients with chronic obstructive pulmonary disease in the primary care setting: focus on the role of spirometry and bronchodilator reversibility
From the Journals
Rehabilitation improves walk test results for post–pulmonary embolism patients with persistent dyspnea
In patients with persistent dyspnea following a pulmonary embolism, rehabilitation should be considered as a treatment option.
Feature
The evolving pulmonary landscape in HIV
“Should management be tailored for people with HIV infection?”
Commentary
The cardiopulmonary effects of mask wearing
Clearly, this study lets us conclude that mask wearing at rest has less of an effect than mask wearing during exercise. But remember that, in...
Feature
Wildfire smoke and air quality: How long could health effects last?
The effects of smoke from wildfires can continue for many years.
Livin' on the MDedge
The enemy of carcinogenic fumes is my friendly begonia
Also: Driving the gastrointestinal highway and pulling the plug on an unsupervised chatbot.
Conference Coverage
ILD risk elevated in RA, PsA after starting biologic or targeted synthetic DMARDs
The risk for interstitial lung disease in patients with PsA during the first 5 years after starting a biologic or targeted synthetic DMARD was...